MyFinsight
Home
Blog
About
Short-term investments
$255,898K
(32.82%↑ Y/Y)
Cash and cash
equivalents
$78,640K
(7.99%↑ Y/Y)
Prepaid expenses and
other current assets
$7,436K
(-28.70%↓ Y/Y)
Total current assets
$341,974K
(23.94%↑ Y/Y)
Long-term investments
$19,020K
(-92.15%↓ Y/Y)
Operating lease
right-of-use assets
$2,233K
(89.24%↑ Y/Y)
Other assets
$297K
(-19.07%↓ Y/Y)
Property and equipment,
net
$263K
(-53.78%↓ Y/Y)
Total assets
$363,787K
(-30.09%↓ Y/Y)
Total liabilities and
stockholders' equity
$363,787K
(-30.09%↓ Y/Y)
Total stockholders'
equity
$321,754K
(-34.62%↓ Y/Y)
Total liabilities
$42,033K
(49.14%↑ Y/Y)
Total cullinan
stockholders' equity
$321,754K
(-34.62%↓ Y/Y)
Total current
liabilities
$40,628K
(44.80%↑ Y/Y)
Operating lease
liabilities, net of current...
$1,405K
(1024.00%↑ Y/Y)
Accumulated deficit
-$691,484K
(-42.05%↓ Y/Y)
Accumulated other
comprehensive income (loss)
-$134K
(-122.08%↓ Y/Y)
Additional paid-in capital
$1,013,366K
(3.58%↑ Y/Y)
Accrued expenses and
other current...
$36,237K
(49.72%↑ Y/Y)
Accounts payable
$3,725K
(51.36%↑ Y/Y)
Operating lease
liabilities, current
$666K
(-52.22%↓ Y/Y)
Common stock, 0.0001
par value,...
$6K
(0.00%↑ Y/Y)
Back
Back
Balance Sheet
Cullinan Therapeutics, Inc. (CGEM)
Cullinan Therapeutics, Inc. (CGEM)
source: myfinsight.com